Impact of Coronary Sinus Reducer on the Extent of Ischemia in Functional Stress Tests

BACKGROUND: The coronary sinus reducer is an established therapy for patients with refractory angina due to obstructive coronary artery disease who are not candidates for further revascularization. Although symptomatic benefits are well documented, its effect on objective measures of ischemia remains unclear. This study aimed to evaluate the association between coronary sinus reducer implantation and inducible myocardial ischemia assessed by functional stress testing. METHODS: We retrospectively analyzed a prospectively maintained registry of consecutive patients undergoing coronary sinus reducer implantation between 2011 and 2024. Baseline assessment included Canadian Cardiovascular Society angina class, 6-minute walk test, stress echocardiography, and dipyridamole single-photon emission computed tomography imaging, repeated at 6 months. Coprimary outcomes were changes in stress wall motion score index and in the proportion of patients with moderate or severe ischemia on single-photon emission computed tomography. Clinical nonresponders were defined as no improvement in Canadian Cardiovascular Society class at 12 months. RESULTS: Among 153 treated patients, 118 had complete imaging data. Median stress wall motion score index improved from 1.38 to 1.23 ( P <0.001), and stress left ventricular ejection fraction increased from 55% to 60% ( P =0.019). The proportion of patients with moderate or severe ischemia on single-photon emission computed tomography decreased from 52% to 24% ( P <0.001). The summed difference score, available in 45 patients, did not change significantly. Clinically, 86% improved by ≥1 Canadian Cardiovascular Society class at 6 months. CONCLUSIONS: Coronary sinus reducer implantation was associated with reduced inducible ischemia on stress echocardiography and with clinical improvement. The proportion of patients with moderate or severe ischemia on single-photon emission computed tomography decreased following Reducer implantation.

Authors

Institutions

Publication Details

Journal
Circulation Cardiovascular Interventions
Published
2026-11-13
DOI
https://doi.org/10.1161/circinterventions.126.017002
Primary Topic
Cardiac Imaging and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of Coronary Sinus Reducer on the Extent of Ischemia in Functional Stress Tests

Miri Revivo, Haim Shmilovich, Sheizaf Gefen, Jeremy Ben‐Shoshan et al.
1 links
Circulation Cardiovascular Interventions
Cardiac Imaging and Diagnostics
article

Impact of Coronary Sinus Reducer on the Extent of Ischemia in Functional Stress Tests

Miri Revivo, Haim Shmilovich, Sheizaf Gefen, Jeremy Ben‐Shoshan, Maayan Konigstein, Shmuel Banai, Elina Stsiapanava, Gil Mashiah, Yoav Perez
article en

Abstract

BACKGROUND: The coronary sinus reducer is an established therapy for patients with refractory angina due to obstructive coronary artery disease who are not candidates for further revascularization. Although symptomatic benefits are well documented, its effect on objective measures of ischemia remains unclear. This study aimed to evaluate the association between coronary sinus reducer implantation and inducible myocardial ischemia assessed by functional stress testing. METHODS: We retrospectively analyzed a prospectively maintained registry of consecutive patients undergoing coronary sinus reducer implantation between 2011 and 2024. Baseline assessment included Canadian Cardiovascular Society angina class, 6-minute walk test, stress echocardiography, and dipyridamole single-photon emission computed tomography imaging, repeated at 6 months. Coprimary outcomes were changes in stress wall motion score index and in the proportion of patients with moderate or severe ischemia on single-photon emission computed tomography. Clinical nonresponders were defined as no improvement in Canadian Cardiovascular Society class at 12 months. RESULTS: Among 153 treated patients, 118 had complete imaging data. Median stress wall motion score index improved from 1.38 to 1.23 ( P <0.001), and stress left ventricular ejection fraction increased from 55% to 60% ( P =0.019). The proportion of patients with moderate or severe ischemia on single-photon emission computed tomography decreased from 52% to 24% ( P <0.001). The summed difference score, available in 45 patients, did not change significantly. Clinically, 86% improved by ≥1 Canadian Cardiovascular Society class at 6 months. CONCLUSIONS: Coronary sinus reducer implantation was associated with reduced inducible ischemia on stress echocardiography and with clinical improvement. The proportion of patients with moderate or severe ischemia on single-photon emission computed tomography decreased following Reducer implantation.

Circulation Cardiovascular Interventions
Tel Aviv University (IL), Tel Aviv Sourasky Medical Center (IL)
Good health and well-being
Cardiac Imaging and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon